Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation

Clinical Infectious Diseases

Volumn 25, Issue 4, 1997, Pages 908-910

  Marr, Kieren A ^a   White, Theodore C ^b   Van Burik, Jo Anne H ^b   Bowden, Raleigh A ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUCONAZOLE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; VANCOMYCIN; VINCRISTINE SULFATE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANDIDIASIS; CASE REPORT; CORTICOSTEROID THERAPY; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MALE; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030761555     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515553     Document Type: Article

References (13)

1. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994;18:273-84.
2. Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ. Isolation of fiuconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis 1995;20:77-83.
3. Nolte FS, Parkinson T, Falconer DJ, et al. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 1997;41:196-9.
4. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. NCCLS document M27-P. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1992.
5. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1-8.
6. Sadhu C, McEachem MI, Rustchenko-Bulgac EP, Schmid J, Soll DR, Hicks JB. Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification. J Bacteriol 1991;173:842-50.
7. Hoffman CS, Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 1987;57:267-72.
8. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1982.
9. Schmid J, Tay YP, Wan L, et al. Evidence for nosocomial transmission of Candida albicans obtained by Ca3 fingerprinting. J Clin Microbiol 1995;33:1223-30.
10. Stevens DA, Odds FC, Scherer S. Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis 1990;12:258-66.
11. Pfaller MA, Rhine-Chalberg J, Redding SW, et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994;32:59-64.
12. White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Diseases 1997;3(suppl 1):S1-8.
13. Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991;45:187-218.